MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer
Robert Hudson(National Cancer Institute), Stefan Ambs(University of Maryland, Baltimore), Harris G. Yfantis(University of Maryland, Baltimore), Tiffany H. Dorsey(Center for Cancer Research), Dominic Esposito(Leidos (United States)), Michael J. Naslund(University of Maryland, Baltimore), Carlo M. Croce(The Ohio State University), Ming Yi(Science Applications International Corporation (United States)), Robert M. Stephens(National Cancer Institute), Richard B. Alexander, Arthur A. Hurwitz(SUNY Upstate Medical University), James F. Borin, Dong Hoon Lee(Korea University), Stephanie K. Watkins(University of Maryland, Baltimore)
Cited by 189
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior
|Journal of Clinical Oncology|2006|778